Abiopharma

Clinical trial NCT06798896 updates: 1. completion date: 2026-10-01 → 2027-08-01 2. primary completion date: 2026-10-01 → 2027-08-01 3. enrollment: 258 → 216 participants

Clinical trial NCT07594600 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-01 → 2026-05-25

Clinical trial NCT04349995 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-28 → 2025-05-28

Clinical trial NCT06003231: primary completion date: 2026-05-31 → 2026-03-27.

Clinical trial NCT02451982 updates: 1. completion date: 2026-05-31 → 2026-09-30 2. primary completion date: 2026-05-31 → 2026-09-30

Clinical trial NCT06931691 updates: 1. completion date: 2027-04-20 → 2027-04-21 2. primary completion date: 2027-04-20 → 2027-04-21

Clinical trial NCT06488703 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2025-07-31 → 2025-06-20 3. primary completion date: 2025-07-31 → 2025-06-20 4. enrollment: 52000 → 107032 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05014789: enrollment: 33 → 66 participants.

Clinical trial NCT06857955 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 380 → 385 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07498335 updates: 1. start date: 2026-10-02 → 2026-08-26 2. completion date: 2031-01-31 → 2032-12-13 3. primary completion date: 2030-11-29 → 2031-09-15